ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global IL-17 Targeting Biological Drugs Market Research Report 2024
Published Date: July 2024
|
Report Code: QYRE-Auto-15Y17729
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global IL 17 Targeting Biological Drugs Market Research Report 2024
BUY CHAPTERS

Global IL-17 Targeting Biological Drugs Market Research Report 2024

Code: QYRE-Auto-15Y17729
Report
July 2024
Pages:84
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Chongqing Genrix Biopharmaceutical
Jiangsu Hengrui Medicine
Novartis
UCB
Eli Lilly and Co
Astrazeneca plc
DICE THERAPEUTICS
Akesobio

IL-17 Targeting Biological Drugs Market

IL-17 (interleukin-17) is an important pro-inflammatory cytokine that plays an important role in the pathological process of autoimmune diseases such as psoriasis and rheumatoid arthritis. Biological drugs targeting IL-17 reduce inflammatory responses and disease symptoms by inhibiting the activity of IL-17 or its receptors.
The global IL-17 Targeting Biological Drugs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
North American market for IL-17 Targeting Biological Drugs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for IL-17 Targeting Biological Drugs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of IL-17 Targeting Biological Drugs include Chongqing Genrix Biopharmaceutical, Jiangsu Hengrui Medicine, Novartis, UCB, Eli Lilly and Co., Akesobio, AstraZeneca, DICE Therapeutics, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for IL-17 Targeting Biological Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding IL-17 Targeting Biological Drugs.
The IL-17 Targeting Biological Drugs market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global IL-17 Targeting Biological Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the IL-17 Targeting Biological Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of IL-17 Targeting Biological Drugs Market Report

Report Metric Details
Report Name IL-17 Targeting Biological Drugs Market
Segment by Type
  • Oral
  • Injection
Segment by Application
  • Hospital
  • Clinic
  • Other
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Chongqing Genrix Biopharmaceutical, Jiangsu Hengrui Medicine, Novartis, UCB, Eli Lilly and Co., Akesobio, AstraZeneca, DICE Therapeutics
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of IL-17 Targeting Biological Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of IL-17 Targeting Biological Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the IL-17 Targeting Biological Drugs Market report?

Ans: The main players in the IL-17 Targeting Biological Drugs Market are Chongqing Genrix Biopharmaceutical, Jiangsu Hengrui Medicine, Novartis, UCB, Eli Lilly and Co., Akesobio, AstraZeneca, DICE Therapeutics

What are the Application segmentation covered in the IL-17 Targeting Biological Drugs Market report?

Ans: The Applications covered in the IL-17 Targeting Biological Drugs Market report are Hospital, Clinic, Other

What are the Type segmentation covered in the IL-17 Targeting Biological Drugs Market report?

Ans: The Types covered in the IL-17 Targeting Biological Drugs Market report are Oral, Injection

1 IL-17 Targeting Biological Drugs Market Overview
1.1 Product Definition
1.2 IL-17 Targeting Biological Drugs by Type
1.2.1 Global IL-17 Targeting Biological Drugs Market Value Comparison by Type (2024-2030)
1.2.2 Oral
1.2.3 Injection
1.3 IL-17 Targeting Biological Drugs by Application
1.3.1 Global IL-17 Targeting Biological Drugs Market Value by Application (2024-2030)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Global IL-17 Targeting Biological Drugs Market Size Estimates and Forecasts
1.4.1 Global IL-17 Targeting Biological Drugs Revenue 2019-2030
1.4.2 Global IL-17 Targeting Biological Drugs Sales 2019-2030
1.4.3 Global IL-17 Targeting Biological Drugs Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 IL-17 Targeting Biological Drugs Market Competition by Manufacturers
2.1 Global IL-17 Targeting Biological Drugs Sales Market Share by Manufacturers (2019-2024)
2.2 Global IL-17 Targeting Biological Drugs Revenue Market Share by Manufacturers (2019-2024)
2.3 Global IL-17 Targeting Biological Drugs Average Price by Manufacturers (2019-2024)
2.4 Global Key Players of IL-17 Targeting Biological Drugs, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of IL-17 Targeting Biological Drugs, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of IL-17 Targeting Biological Drugs, Product Type & Application
2.7 Global Key Manufacturers of IL-17 Targeting Biological Drugs, Date of Enter into This Industry
2.8 Global IL-17 Targeting Biological Drugs Market Competitive Situation and Trends
2.8.1 Global IL-17 Targeting Biological Drugs Market Concentration Rate
2.8.2 The Global 5 and 10 Largest IL-17 Targeting Biological Drugs Players Market Share by Revenue
2.8.3 Global IL-17 Targeting Biological Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global IL-17 Targeting Biological Drugs Market Scenario by Region
3.1 Global IL-17 Targeting Biological Drugs Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global IL-17 Targeting Biological Drugs Sales by Region: 2019-2030
3.2.1 Global IL-17 Targeting Biological Drugs Sales by Region: 2019-2024
3.2.2 Global IL-17 Targeting Biological Drugs Sales by Region: 2025-2030
3.3 Global IL-17 Targeting Biological Drugs Revenue by Region: 2019-2030
3.3.1 Global IL-17 Targeting Biological Drugs Revenue by Region: 2019-2024
3.3.2 Global IL-17 Targeting Biological Drugs Revenue by Region: 2025-2030
3.4 North America IL-17 Targeting Biological Drugs Market Facts & Figures by Country
3.4.1 North America IL-17 Targeting Biological Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America IL-17 Targeting Biological Drugs Sales by Country (2019-2030)
3.4.3 North America IL-17 Targeting Biological Drugs Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe IL-17 Targeting Biological Drugs Market Facts & Figures by Country
3.5.1 Europe IL-17 Targeting Biological Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe IL-17 Targeting Biological Drugs Sales by Country (2019-2030)
3.5.3 Europe IL-17 Targeting Biological Drugs Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific IL-17 Targeting Biological Drugs Market Facts & Figures by Region
3.6.1 Asia Pacific IL-17 Targeting Biological Drugs Market Size by Region: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific IL-17 Targeting Biological Drugs Sales by Region (2019-2030)
3.6.3 Asia Pacific IL-17 Targeting Biological Drugs Revenue by Region (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America IL-17 Targeting Biological Drugs Market Facts & Figures by Country
3.7.1 Latin America IL-17 Targeting Biological Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America IL-17 Targeting Biological Drugs Sales by Country (2019-2030)
3.7.3 Latin America IL-17 Targeting Biological Drugs Revenue by Country
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa IL-17 Targeting Biological Drugs Market Facts & Figures by Country
3.8.1 Middle East and Africa IL-17 Targeting Biological Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa IL-17 Targeting Biological Drugs Sales by Country (2019-2030)
3.8.3 Middle East and Africa IL-17 Targeting Biological Drugs Revenue by Country
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global IL-17 Targeting Biological Drugs Sales by Type (2019-2030)
4.1.1 Global IL-17 Targeting Biological Drugs Sales by Type (2019-2024)
4.1.2 Global IL-17 Targeting Biological Drugs Sales by Type (2025-2030)
4.1.3 Global IL-17 Targeting Biological Drugs Sales Market Share by Type (2019-2030)
4.2 Global IL-17 Targeting Biological Drugs Revenue by Type (2019-2030)
4.2.1 Global IL-17 Targeting Biological Drugs Revenue by Type (2019-2024)
4.2.2 Global IL-17 Targeting Biological Drugs Revenue by Type (2025-2030)
4.2.3 Global IL-17 Targeting Biological Drugs Revenue Market Share by Type (2019-2030)
4.3 Global IL-17 Targeting Biological Drugs Price by Type (2019-2030)
5 Segment by Application
5.1 Global IL-17 Targeting Biological Drugs Sales by Application (2019-2030)
5.1.1 Global IL-17 Targeting Biological Drugs Sales by Application (2019-2024)
5.1.2 Global IL-17 Targeting Biological Drugs Sales by Application (2025-2030)
5.1.3 Global IL-17 Targeting Biological Drugs Sales Market Share by Application (2019-2030)
5.2 Global IL-17 Targeting Biological Drugs Revenue by Application (2019-2030)
5.2.1 Global IL-17 Targeting Biological Drugs Revenue by Application (2019-2024)
5.2.2 Global IL-17 Targeting Biological Drugs Revenue by Application (2025-2030)
5.2.3 Global IL-17 Targeting Biological Drugs Revenue Market Share by Application (2019-2030)
5.3 Global IL-17 Targeting Biological Drugs Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Chongqing Genrix Biopharmaceutical
6.1.1 Chongqing Genrix Biopharmaceutical Company Information
6.1.2 Chongqing Genrix Biopharmaceutical Description and Business Overview
6.1.3 Chongqing Genrix Biopharmaceutical IL-17 Targeting Biological Drugs Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Chongqing Genrix Biopharmaceutical IL-17 Targeting Biological Drugs Product Portfolio
6.1.5 Chongqing Genrix Biopharmaceutical Recent Developments/Updates
6.2 Jiangsu Hengrui Medicine
6.2.1 Jiangsu Hengrui Medicine Company Information
6.2.2 Jiangsu Hengrui Medicine Description and Business Overview
6.2.3 Jiangsu Hengrui Medicine IL-17 Targeting Biological Drugs Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Jiangsu Hengrui Medicine IL-17 Targeting Biological Drugs Product Portfolio
6.2.5 Jiangsu Hengrui Medicine Recent Developments/Updates
6.3 Novartis
6.3.1 Novartis Company Information
6.3.2 Novartis Description and Business Overview
6.3.3 Novartis IL-17 Targeting Biological Drugs Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Novartis IL-17 Targeting Biological Drugs Product Portfolio
6.3.5 Novartis Recent Developments/Updates
6.4 UCB
6.4.1 UCB Company Information
6.4.2 UCB Description and Business Overview
6.4.3 UCB IL-17 Targeting Biological Drugs Sales, Revenue and Gross Margin (2019-2024)
6.4.4 UCB IL-17 Targeting Biological Drugs Product Portfolio
6.4.5 UCB Recent Developments/Updates
6.5 Eli Lilly and Co.
6.5.1 Eli Lilly and Co. Company Information
6.5.2 Eli Lilly and Co. Description and Business Overview
6.5.3 Eli Lilly and Co. IL-17 Targeting Biological Drugs Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Eli Lilly and Co. IL-17 Targeting Biological Drugs Product Portfolio
6.5.5 Eli Lilly and Co. Recent Developments/Updates
6.6 Akesobio
6.6.1 Akesobio Company Information
6.6.2 Akesobio Description and Business Overview
6.6.3 Akesobio IL-17 Targeting Biological Drugs Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Akesobio IL-17 Targeting Biological Drugs Product Portfolio
6.6.5 Akesobio Recent Developments/Updates
6.7 AstraZeneca
6.7.1 AstraZeneca Company Information
6.7.2 AstraZeneca Description and Business Overview
6.7.3 AstraZeneca IL-17 Targeting Biological Drugs Sales, Revenue and Gross Margin (2019-2024)
6.7.4 AstraZeneca IL-17 Targeting Biological Drugs Product Portfolio
6.7.5 AstraZeneca Recent Developments/Updates
6.8 DICE Therapeutics
6.8.1 DICE Therapeutics Company Information
6.8.2 DICE Therapeutics Description and Business Overview
6.8.3 DICE Therapeutics IL-17 Targeting Biological Drugs Sales, Revenue and Gross Margin (2019-2024)
6.8.4 DICE Therapeutics IL-17 Targeting Biological Drugs Product Portfolio
6.8.5 DICE Therapeutics Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 IL-17 Targeting Biological Drugs Industry Chain Analysis
7.2 IL-17 Targeting Biological Drugs Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 IL-17 Targeting Biological Drugs Production Mode & Process
7.4 IL-17 Targeting Biological Drugs Sales and Marketing
7.4.1 IL-17 Targeting Biological Drugs Sales Channels
7.4.2 IL-17 Targeting Biological Drugs Distributors
7.5 IL-17 Targeting Biological Drugs Customers
8 IL-17 Targeting Biological Drugs Market Dynamics
8.1 IL-17 Targeting Biological Drugs Industry Trends
8.2 IL-17 Targeting Biological Drugs Market Drivers
8.3 IL-17 Targeting Biological Drugs Market Challenges
8.4 IL-17 Targeting Biological Drugs Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Chongqing Genrix Biopharmaceutical
Jiangsu Hengrui Medicine
Novartis
UCB
Eli Lilly and Co
Astrazeneca plc
DICE THERAPEUTICS
Akesobio
List of Tables
 Table 1. Global IL-17 Targeting Biological Drugs Market Value Comparison by Type (2024-2030) & (US$ Million)
 Table 2. Global IL-17 Targeting Biological Drugs Market Value by Application (2024-2030) & (US$ Million)
 Table 3. Global IL-17 Targeting Biological Drugs Market Competitive Situation by Manufacturers in 2023
 Table 4. Global IL-17 Targeting Biological Drugs Sales (K Units) of Key Manufacturers (2019-2024)
 Table 5. Global IL-17 Targeting Biological Drugs Sales Market Share by Manufacturers (2019-2024)
 Table 6. Global IL-17 Targeting Biological Drugs Revenue (US$ Million) by Manufacturers (2019-2024)
 Table 7. Global IL-17 Targeting Biological Drugs Revenue Share by Manufacturers (2019-2024)
 Table 8. Global Market IL-17 Targeting Biological Drugs Average Price (US$/Unit) of Key Manufacturers (2019-2024)
 Table 9. Global Key Players of IL-17 Targeting Biological Drugs, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of IL-17 Targeting Biological Drugs, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of IL-17 Targeting Biological Drugs, Product Type & Application
 Table 12. Global Key Manufacturers of IL-17 Targeting Biological Drugs, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global IL-17 Targeting Biological Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in IL-17 Targeting Biological Drugs as of 2023)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global IL-17 Targeting Biological Drugs Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
 Table 17. Global IL-17 Targeting Biological Drugs Sales by Region (2019-2024) & (K Units)
 Table 18. Global IL-17 Targeting Biological Drugs Sales Market Share by Region (2019-2024)
 Table 19. Global IL-17 Targeting Biological Drugs Sales by Region (2025-2030) & (K Units)
 Table 20. Global IL-17 Targeting Biological Drugs Sales Market Share by Region (2025-2030)
 Table 21. Global IL-17 Targeting Biological Drugs Revenue by Region (2019-2024) & (US$ Million)
 Table 22. Global IL-17 Targeting Biological Drugs Revenue Market Share by Region (2019-2024)
 Table 23. Global IL-17 Targeting Biological Drugs Revenue by Region (2025-2030) & (US$ Million)
 Table 24. Global IL-17 Targeting Biological Drugs Revenue Market Share by Region (2025-2030)
 Table 25. North America IL-17 Targeting Biological Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 26. North America IL-17 Targeting Biological Drugs Sales by Country (2019-2024) & (K Units)
 Table 27. North America IL-17 Targeting Biological Drugs Sales by Country (2025-2030) & (K Units)
 Table 28. North America IL-17 Targeting Biological Drugs Revenue by Country (2019-2024) & (US$ Million)
 Table 29. North America IL-17 Targeting Biological Drugs Revenue by Country (2025-2030) & (US$ Million)
 Table 30. Europe IL-17 Targeting Biological Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 31. Europe IL-17 Targeting Biological Drugs Sales by Country (2019-2024) & (K Units)
 Table 32. Europe IL-17 Targeting Biological Drugs Sales by Country (2025-2030) & (K Units)
 Table 33. Europe IL-17 Targeting Biological Drugs Revenue by Country (2019-2024) & (US$ Million)
 Table 34. Europe IL-17 Targeting Biological Drugs Revenue by Country (2025-2030) & (US$ Million)
 Table 35. Asia Pacific IL-17 Targeting Biological Drugs Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
 Table 36. Asia Pacific IL-17 Targeting Biological Drugs Sales by Region (2019-2024) & (K Units)
 Table 37. Asia Pacific IL-17 Targeting Biological Drugs Sales by Region (2025-2030) & (K Units)
 Table 38. Asia Pacific IL-17 Targeting Biological Drugs Revenue by Region (2019-2024) & (US$ Million)
 Table 39. Asia Pacific IL-17 Targeting Biological Drugs Revenue by Region (2025-2030) & (US$ Million)
 Table 40. Latin America IL-17 Targeting Biological Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 41. Latin America IL-17 Targeting Biological Drugs Sales by Country (2019-2024) & (K Units)
 Table 42. Latin America IL-17 Targeting Biological Drugs Sales by Country (2025-2030) & (K Units)
 Table 43. Latin America IL-17 Targeting Biological Drugs Revenue by Country (2019-2024) & (US$ Million)
 Table 44. Latin America IL-17 Targeting Biological Drugs Revenue Market Share by Country (2019-2024)
 Table 45. Middle East and Africa IL-17 Targeting Biological Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 46. Middle East and Africa IL-17 Targeting Biological Drugs Sales by Country (2019-2024) & (K Units)
 Table 47. Middle East and Africa IL-17 Targeting Biological Drugs Sales by Country (2025-2030) & (K Units)
 Table 48. Middle East and Africa IL-17 Targeting Biological Drugs Revenue by Country (2019-2024) & (US$ Million)
 Table 49. Middle East and Africa IL-17 Targeting Biological Drugs Revenue by Country (2025-2030) & (US$ Million)
 Table 50. Global IL-17 Targeting Biological Drugs Sales (K Units) by Type (2019-2024)
 Table 51. Global IL-17 Targeting Biological Drugs Sales (K Units) by Type (2025-2030)
 Table 52. Global IL-17 Targeting Biological Drugs Sales Market Share by Type (2019-2024)
 Table 53. Global IL-17 Targeting Biological Drugs Sales Market Share by Type (2025-2030)
 Table 54. Global IL-17 Targeting Biological Drugs Revenue (US$ Million) by Type (2019-2024)
 Table 55. Global IL-17 Targeting Biological Drugs Revenue (US$ Million) by Type (2025-2030)
 Table 56. Global IL-17 Targeting Biological Drugs Revenue Market Share by Type (2019-2024)
 Table 57. Global IL-17 Targeting Biological Drugs Revenue Market Share by Type (2025-2030)
 Table 58. Global IL-17 Targeting Biological Drugs Price (US$/Unit) by Type (2019-2024)
 Table 59. Global IL-17 Targeting Biological Drugs Price (US$/Unit) by Type (2025-2030)
 Table 60. Global IL-17 Targeting Biological Drugs Sales (K Units) by Application (2019-2024)
 Table 61. Global IL-17 Targeting Biological Drugs Sales (K Units) by Application (2025-2030)
 Table 62. Global IL-17 Targeting Biological Drugs Sales Market Share by Application (2019-2024)
 Table 63. Global IL-17 Targeting Biological Drugs Sales Market Share by Application (2025-2030)
 Table 64. Global IL-17 Targeting Biological Drugs Revenue (US$ Million) by Application (2019-2024)
 Table 65. Global IL-17 Targeting Biological Drugs Revenue (US$ Million) by Application (2025-2030)
 Table 66. Global IL-17 Targeting Biological Drugs Revenue Market Share by Application (2019-2024)
 Table 67. Global IL-17 Targeting Biological Drugs Revenue Market Share by Application (2025-2030)
 Table 68. Global IL-17 Targeting Biological Drugs Price (US$/Unit) by Application (2019-2024)
 Table 69. Global IL-17 Targeting Biological Drugs Price (US$/Unit) by Application (2025-2030)
 Table 70. Chongqing Genrix Biopharmaceutical Company Information
 Table 71. Chongqing Genrix Biopharmaceutical Description and Business Overview
 Table 72. Chongqing Genrix Biopharmaceutical IL-17 Targeting Biological Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 73. Chongqing Genrix Biopharmaceutical IL-17 Targeting Biological Drugs Product
 Table 74. Chongqing Genrix Biopharmaceutical Recent Developments/Updates
 Table 75. Jiangsu Hengrui Medicine Company Information
 Table 76. Jiangsu Hengrui Medicine Description and Business Overview
 Table 77. Jiangsu Hengrui Medicine IL-17 Targeting Biological Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 78. Jiangsu Hengrui Medicine IL-17 Targeting Biological Drugs Product
 Table 79. Jiangsu Hengrui Medicine Recent Developments/Updates
 Table 80. Novartis Company Information
 Table 81. Novartis Description and Business Overview
 Table 82. Novartis IL-17 Targeting Biological Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 83. Novartis IL-17 Targeting Biological Drugs Product
 Table 84. Novartis Recent Developments/Updates
 Table 85. UCB Company Information
 Table 86. UCB Description and Business Overview
 Table 87. UCB IL-17 Targeting Biological Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 88. UCB IL-17 Targeting Biological Drugs Product
 Table 89. UCB Recent Developments/Updates
 Table 90. Eli Lilly and Co. Company Information
 Table 91. Eli Lilly and Co. Description and Business Overview
 Table 92. Eli Lilly and Co. IL-17 Targeting Biological Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 93. Eli Lilly and Co. IL-17 Targeting Biological Drugs Product
 Table 94. Eli Lilly and Co. Recent Developments/Updates
 Table 95. Akesobio Company Information
 Table 96. Akesobio Description and Business Overview
 Table 97. Akesobio IL-17 Targeting Biological Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 98. Akesobio IL-17 Targeting Biological Drugs Product
 Table 99. Akesobio Recent Developments/Updates
 Table 100. AstraZeneca Company Information
 Table 101. AstraZeneca Description and Business Overview
 Table 102. AstraZeneca IL-17 Targeting Biological Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 103. AstraZeneca IL-17 Targeting Biological Drugs Product
 Table 104. AstraZeneca Recent Developments/Updates
 Table 105. DICE Therapeutics Company Information
 Table 106. DICE Therapeutics Description and Business Overview
 Table 107. DICE Therapeutics IL-17 Targeting Biological Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 108. DICE Therapeutics IL-17 Targeting Biological Drugs Product
 Table 109. DICE Therapeutics Recent Developments/Updates
 Table 110. Key Raw Materials Lists
 Table 111. Raw Materials Key Suppliers Lists
 Table 112. IL-17 Targeting Biological Drugs Distributors List
 Table 113. IL-17 Targeting Biological Drugs Customers List
 Table 114. IL-17 Targeting Biological Drugs Market Trends
 Table 115. IL-17 Targeting Biological Drugs Market Drivers
 Table 116. IL-17 Targeting Biological Drugs Market Challenges
 Table 117. IL-17 Targeting Biological Drugs Market Restraints
 Table 118. Research Programs/Design for This Report
 Table 119. Key Data Information from Secondary Sources
 Table 120. Key Data Information from Primary Sources
 Table 121. Authors List of This Report


List of Figures
 Figure 1. Product Picture of IL-17 Targeting Biological Drugs
 Figure 2. Global IL-17 Targeting Biological Drugs Market Value Comparison by Type (2024-2030) & (US$ Million)
 Figure 3. Global IL-17 Targeting Biological Drugs Market Share by Type: 2023 & 2030
 Figure 4. Oral Product Picture
 Figure 5. Injection Product Picture
 Figure 6. Global IL-17 Targeting Biological Drugs Market Value by Application (2024-2030) & (US$ Million)
 Figure 7. Global IL-17 Targeting Biological Drugs Market Share by Application: 2023 & 2030
 Figure 8. Hospital
 Figure 9. Clinic
 Figure 10. Other
 Figure 11. Global IL-17 Targeting Biological Drugs Revenue, (US$ Million), 2019 VS 2023 VS 2030
 Figure 12. Global IL-17 Targeting Biological Drugs Market Size (2019-2030) & (US$ Million)
 Figure 13. Global IL-17 Targeting Biological Drugs Sales (2019-2030) & (K Units)
 Figure 14. Global IL-17 Targeting Biological Drugs Average Price (US$/Unit) & (2019-2030)
 Figure 15. IL-17 Targeting Biological Drugs Report Years Considered
 Figure 16. IL-17 Targeting Biological Drugs Sales Share by Manufacturers in 2023
 Figure 17. Global IL-17 Targeting Biological Drugs Revenue Share by Manufacturers in 2023
 Figure 18. Global 5 and 10 Largest IL-17 Targeting Biological Drugs Players: Market Share by Revenue in IL-17 Targeting Biological Drugs in 2023
 Figure 19. IL-17 Targeting Biological Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
 Figure 20. Global IL-17 Targeting Biological Drugs Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
 Figure 21. North America IL-17 Targeting Biological Drugs Sales Market Share by Country (2019-2030)
 Figure 22. North America IL-17 Targeting Biological Drugs Revenue Market Share by Country (2019-2030)
 Figure 23. United States IL-17 Targeting Biological Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 24. Canada IL-17 Targeting Biological Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 25. Europe IL-17 Targeting Biological Drugs Sales Market Share by Country (2019-2030)
 Figure 26. Europe IL-17 Targeting Biological Drugs Revenue Market Share by Country (2019-2030)
 Figure 27. Germany IL-17 Targeting Biological Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 28. France IL-17 Targeting Biological Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 29. U.K. IL-17 Targeting Biological Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 30. Italy IL-17 Targeting Biological Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 31. Russia IL-17 Targeting Biological Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 32. Asia Pacific IL-17 Targeting Biological Drugs Sales Market Share by Region (2019-2030)
 Figure 33. Asia Pacific IL-17 Targeting Biological Drugs Revenue Market Share by Region (2019-2030)
 Figure 34. China IL-17 Targeting Biological Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 35. Japan IL-17 Targeting Biological Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 36. South Korea IL-17 Targeting Biological Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 37. India IL-17 Targeting Biological Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 38. Australia IL-17 Targeting Biological Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 39. China Taiwan IL-17 Targeting Biological Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 40. Southeast Asia IL-17 Targeting Biological Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 41. Latin America IL-17 Targeting Biological Drugs Sales Market Share by Country (2019-2030)
 Figure 42. Mexico IL-17 Targeting Biological Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 43. Brazil IL-17 Targeting Biological Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 44. Argentina IL-17 Targeting Biological Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 45. Colombia IL-17 Targeting Biological Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 46. Middle East and Africa IL-17 Targeting Biological Drugs Sales Market Share by Country (2019-2030)
 Figure 47. Middle East and Africa IL-17 Targeting Biological Drugs Revenue Market Share by Country (2019-2030)
 Figure 48. Turkey IL-17 Targeting Biological Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 49. Saudi Arabia IL-17 Targeting Biological Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 50. UAE IL-17 Targeting Biological Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 51. Global Sales Market Share of IL-17 Targeting Biological Drugs by Type (2019-2030)
 Figure 52. Global Revenue Market Share of IL-17 Targeting Biological Drugs by Type (2019-2030)
 Figure 53. Global IL-17 Targeting Biological Drugs Price (US$/Unit) by Type (2019-2030)
 Figure 54. Global Sales Market Share of IL-17 Targeting Biological Drugs by Application (2019-2030)
 Figure 55. Global Revenue Market Share of IL-17 Targeting Biological Drugs by Application (2019-2030)
 Figure 56. Global IL-17 Targeting Biological Drugs Price (US$/Unit) by Application (2019-2030)
 Figure 57. IL-17 Targeting Biological Drugs Value Chain
 Figure 58. IL-17 Targeting Biological Drugs Production Process
 Figure 59. Channels of Distribution (Direct Vs Distribution)
 Figure 60. Bottom-up and Top-down Approaches for This Report
 Figure 61. Data Triangulation
 Figure 62. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Nano String

SIMILAR REPORTS

Global Interleukin 17 Inhibitors Market Research Report 2024
Global IL 17 Monoclonal Antibody Injections Market Research Report 2024
Global IL 17 Inhibitors for Psoriasis Market Research Report 2024
Global Interleukin Inhibitors for Psoriasis Market Research Report 2024
Global Interleukin 17A Market Research Report 2025
Global Secukinumab Market Research Report 2024
Global Biologic Medications for Psoriasis Market Research Report 2024
Global Monoclonal Antibodies for Plaque Psoriasis Market Research Report 2024
Global TYK2 Targeting Drugs Market Research Report 2024
Global Interleukin 17A IL 17A ELISA Kit Market Research Report 2024
Global Psoriasis Biologics Drugs Market Research Report 2025
Global Autoimmune Disease Drugs Market Research Report 2025
Autoimmune Therapeutics Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Rheumatology Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global IL 23 Receptor Antagonist Market Research Report 2024
Global Biologics and Biosimilars Market Research Report 2025
Anti inflammatory Therapy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Autoimmune Diseases Treatment Market Research Report 2024
Global Innovations in Biologics and Biosimilars Market Research Report 2024
Biotech Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

RELATED REPORTS

Global Pharma and Healthcare Social Media Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-14Y6812
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Food Additives Testing Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-34O3983
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Gabapentin API Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-9V17601
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Electronic Informed Consent Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-22C17047
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions